Rachel Huddart

2.1k total citations · 1 hit paper
14 papers, 1.0k citations indexed

About

Rachel Huddart is a scholar working on Pharmacology, Molecular Biology and Genetics. According to data from OpenAlex, Rachel Huddart has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Rachel Huddart's work include Pharmacogenetics and Drug Metabolism (7 papers), Biomedical Text Mining and Ontologies (3 papers) and Pharmaceutical studies and practices (3 papers). Rachel Huddart is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Biomedical Text Mining and Ontologies (3 papers) and Pharmaceutical studies and practices (3 papers). Rachel Huddart collaborates with scholars based in United States, Spain and United Kingdom. Rachel Huddart's co-authors include Teri E. Klein, Michelle Whirl‐Carrillo, Katrin Sangkuhl, Li Gong, Ryan Whaley, Caroline F. Thorn, Russ B. Altman, Alison E. Fohner, Daniel F. Carlson and Chris Proudfoot and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Pharmacogenetics and Genomics and Transgenic Research.

In The Last Decade

Rachel Huddart

14 papers receiving 983 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine

2021 410 citations Michelle Whirl‐Carrillo, Rachel Huddart et al. Clinical Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rachel Huddart United States	11	385	349	279	189	132	14	1.0k
Amy Price United Kingdom	6	302 0.8×	406 1.2×	121 0.4×	224 1.2×	115 0.9×	12	1.3k
Fengxiang Yan China	12	257 0.7×	331 0.9×	113 0.4×	95 0.5×	217 1.6×	25	935
Russell Gotschall United States	21	391 1.0×	533 1.5×	320 1.1×	116 0.6×	112 0.8×	37	1.7k
Miriam Saiz‐Rodríguez Spain	19	351 0.9×	191 0.5×	47 0.2×	176 0.9×	116 0.9×	58	984
Scott Q. Siler United States	19	412 1.1×	275 0.8×	57 0.2×	107 0.6×	43 0.3×	30	1.4k
Yuan Ming Di Australia	13	220 0.6×	275 0.8×	38 0.1×	105 0.6×	115 0.9×	22	938
Ryoko Yoshida Japan	23	438 1.1×	680 1.9×	129 0.5×	44 0.2×	69 0.5×	44	1.7k
G. Hanton France	16	183 0.5×	805 2.3×	60 0.2×	45 0.2×	59 0.4×	41	1.4k
Alex Hemeryck Belgium	12	204 0.5×	220 0.6×	42 0.2×	62 0.3×	139 1.1×	15	784
Hong-Hao Zhou China	15	238 0.6×	281 0.8×	47 0.2×	51 0.3×	96 0.7×	52	735

Countries citing papers authored by Rachel Huddart

Since Specialization

Citations

This map shows the geographic impact of Rachel Huddart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Huddart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Huddart more than expected).

Fields of papers citing papers by Rachel Huddart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Huddart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Huddart. The network helps show where Rachel Huddart may publish in the future.

Co-authorship network of co-authors of Rachel Huddart

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Huddart. A scholar is included among the top collaborators of Rachel Huddart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Huddart. Rachel Huddart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Duarte, Julio D., Cameron D. Thomas, Craig R. Lee, et al.. (2024). Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy. Clinical Pharmacology & Therapeutics. 116(4). 939–947. 22 indexed citations

Huddart, Rachel, et al.. (2022). PharmGKB summary: heparin-induced thrombocytopenia pathway, adverse drug reaction.. PubMed. 32(3). 117–124. 1 indexed citations

Whirl‐Carrillo, Michelle, Rachel Huddart, Li Gong, et al.. (2021). An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine. Clinical Pharmacology & Therapeutics. 110(3). 563–572. 410 indexed citations breakdown →

McDermott, John, Joshua Wolf, Keito Hoshitsuki, et al.. (2021). Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT‐RNR1 Genotype. Clinical Pharmacology & Therapeutics. 111(2). 366–372. 53 indexed citations

Huddart, Rachel, Michelle Whirl‐Carrillo, Russ B. Altman, & Teri E. Klein. (2020). PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID‐19. Clinical Pharmacology & Therapeutics. 109(1). 116–122. 7 indexed citations

Karnes, Jason H., Allan E. Rettie, Andrew A. Somogyi, et al.. (2020). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update. Clinical Pharmacology & Therapeutics. 109(2). 302–309. 104 indexed citations

Huddart, Rachel, Katrin Sangkuhl, Michelle Whirl‐Carrillo, & Teri E. Klein. (2019). Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?. Clinical Pharmacology & Therapeutics. 106(2). 284–286. 27 indexed citations

Lever, Jake, Julia M. Barbarino, Li Gong, et al.. (2019). PGxMine: Text mining for curation of PharmGKB. PubMed. 25. 611–622. 12 indexed citations

Huddart, Rachel, Russ B. Altman, & Teri E. Klein. (2019). PharmGKB summary. Pharmacogenetics and Genomics. 29(4). 91–97. 8 indexed citations

10.

Huddart, Rachel, Laura B. Ramsey, Jeffrey R. Strawn, et al.. (2019). PharmGKB summary: sertraline pathway, pharmacokinetics. Pharmacogenetics and Genomics. 30(2). 26–33. 40 indexed citations

11.

Huddart, Rachel, Melissa Clarke, Russ B. Altman, & Teri E. Klein. (2018). PharmGKB summary. Pharmacogenetics and Genomics. 28(10). 230–237. 27 indexed citations

12.

Huddart, Rachel, J. Steven Leeder, Russ B. Altman, & Teri E. Klein. (2018). PharmGKB summary. Pharmacogenetics and Genomics. 28(4). 110–115. 15 indexed citations

13.

Huddart, Rachel, Alison E. Fohner, Michelle Whirl‐Carrillo, et al.. (2018). Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research. Clinical Pharmacology & Therapeutics. 105(5). 1256–1262. 97 indexed citations

14.

Proudfoot, Chris, Daniel F. Carlson, Rachel Huddart, et al.. (2014). Genome edited sheep and cattle. Transgenic Research. 24(1). 147–153. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact